Can Chronic Nitric Oxide Inhibition Improve Liver and Renal Dysfunction in Bile Duct Ligated Rats?

The aims of the present work were to study the effects of chronic NO inhibition on liver cirrhosis and to analyze its relationship with liver and kidney damage markers. Two inhibitors of NO synthesis (inducible NO synthase (iNOS) inhibitor, aminoguanidine (AG), and nonselective NOS inhibitor, L-nitr...

Full description

Saved in:
Bibliographic Details
Main Authors: Mona Fouad Mahmoud, Sara Zakaria, Ahmed Fahmy
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Advances in Pharmacological Sciences
Online Access:http://dx.doi.org/10.1155/2015/298792
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832564248989925376
author Mona Fouad Mahmoud
Sara Zakaria
Ahmed Fahmy
author_facet Mona Fouad Mahmoud
Sara Zakaria
Ahmed Fahmy
author_sort Mona Fouad Mahmoud
collection DOAJ
description The aims of the present work were to study the effects of chronic NO inhibition on liver cirrhosis and to analyze its relationship with liver and kidney damage markers. Two inhibitors of NO synthesis (inducible NO synthase (iNOS) inhibitor, aminoguanidine (AG), and nonselective NOS inhibitor, L-nitroarginine methyl ester (L-NAME)) were administered for 6 weeks to bile duct ligated (BDL) rats 3 days after surgery. The present study showed that BDL was associated with liver injury and renal impairment. BDL increased liver NO content and myeloperoxidase (MPO) activity. This was corroborated by increased oxidative stress, TNF-α, TGF-1β, and MMP-13 genes overexpression. Although both drugs reduced NO synthesis and TNF-α gene overexpression, only AG improved renal dysfunction and liver damage and reduced liver oxidative stress. However, L-NAME exacerbated liver and renal dysfunction. Both drugs failed to modulate TGF-1β and MMP-13 genes overexpression. In conclusion, inhibition of NO production by constitutive nitric oxide synthase (cNOS) plays a crucial role in liver injury and renal dysfunction while inhibition of iNOS by AG has beneficial effect. TNF-α is not the main cytokine responsible for liver injury in BDL model. Nitric oxide inhibition did not stop the progression of cholestatic liver damage.
format Article
id doaj-art-26073b3621964c51ab8524a1b3bb5530
institution Kabale University
issn 1687-6334
1687-6342
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Advances in Pharmacological Sciences
spelling doaj-art-26073b3621964c51ab8524a1b3bb55302025-02-03T01:11:26ZengWileyAdvances in Pharmacological Sciences1687-63341687-63422015-01-01201510.1155/2015/298792298792Can Chronic Nitric Oxide Inhibition Improve Liver and Renal Dysfunction in Bile Duct Ligated Rats?Mona Fouad Mahmoud0Sara Zakaria1Ahmed Fahmy2Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Zagazig, Zagazig 44519, EgyptDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, University of Zagazig, Zagazig 44519, EgyptDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, University of Zagazig, Zagazig 44519, EgyptThe aims of the present work were to study the effects of chronic NO inhibition on liver cirrhosis and to analyze its relationship with liver and kidney damage markers. Two inhibitors of NO synthesis (inducible NO synthase (iNOS) inhibitor, aminoguanidine (AG), and nonselective NOS inhibitor, L-nitroarginine methyl ester (L-NAME)) were administered for 6 weeks to bile duct ligated (BDL) rats 3 days after surgery. The present study showed that BDL was associated with liver injury and renal impairment. BDL increased liver NO content and myeloperoxidase (MPO) activity. This was corroborated by increased oxidative stress, TNF-α, TGF-1β, and MMP-13 genes overexpression. Although both drugs reduced NO synthesis and TNF-α gene overexpression, only AG improved renal dysfunction and liver damage and reduced liver oxidative stress. However, L-NAME exacerbated liver and renal dysfunction. Both drugs failed to modulate TGF-1β and MMP-13 genes overexpression. In conclusion, inhibition of NO production by constitutive nitric oxide synthase (cNOS) plays a crucial role in liver injury and renal dysfunction while inhibition of iNOS by AG has beneficial effect. TNF-α is not the main cytokine responsible for liver injury in BDL model. Nitric oxide inhibition did not stop the progression of cholestatic liver damage.http://dx.doi.org/10.1155/2015/298792
spellingShingle Mona Fouad Mahmoud
Sara Zakaria
Ahmed Fahmy
Can Chronic Nitric Oxide Inhibition Improve Liver and Renal Dysfunction in Bile Duct Ligated Rats?
Advances in Pharmacological Sciences
title Can Chronic Nitric Oxide Inhibition Improve Liver and Renal Dysfunction in Bile Duct Ligated Rats?
title_full Can Chronic Nitric Oxide Inhibition Improve Liver and Renal Dysfunction in Bile Duct Ligated Rats?
title_fullStr Can Chronic Nitric Oxide Inhibition Improve Liver and Renal Dysfunction in Bile Duct Ligated Rats?
title_full_unstemmed Can Chronic Nitric Oxide Inhibition Improve Liver and Renal Dysfunction in Bile Duct Ligated Rats?
title_short Can Chronic Nitric Oxide Inhibition Improve Liver and Renal Dysfunction in Bile Duct Ligated Rats?
title_sort can chronic nitric oxide inhibition improve liver and renal dysfunction in bile duct ligated rats
url http://dx.doi.org/10.1155/2015/298792
work_keys_str_mv AT monafouadmahmoud canchronicnitricoxideinhibitionimproveliverandrenaldysfunctioninbileductligatedrats
AT sarazakaria canchronicnitricoxideinhibitionimproveliverandrenaldysfunctioninbileductligatedrats
AT ahmedfahmy canchronicnitricoxideinhibitionimproveliverandrenaldysfunctioninbileductligatedrats